Mr. Claiborne brings extensive experience in leadership roles with clinical and commercial stage, publicly traded biopharmaceutical companies.

Dr. Wamhoff is a founder of HemoShear where he co-developed HemoShear’s REVEAL-Tx™ drug discovery platform.

For more than 15 years, the Focused Ultrasound Foundation has been dedicated to advancing the development and adoption of focused ultrasound.

Company plans to submit ONWARD results to both European and U.S. regulatory agencies.

Two-year export program provides resources to support international business expansion.

The quest for funding can be a stressful experience for entrepreneurs hoping to launch a biotech startup. The need for seed funding is essential but where are the best sources?

The technology is being utilized to launch a portfolio of 10+ clinical tests over the next five years to provide decision support for diseases affecting more than 50 million Americans.

ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies.

AgroSpheres’ AgriCell technology will help deliver the next generation of high-performing, environmentally safe crop protection

BIO-CAT Microbials continues to scale up their probiotic pipeline with their latest microbial strain, Bacillus subtilis BS50.

Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.

What does Storyware do? Storyware is in the business of crafting creative digital solutions for our clients. This includes designing websites, building web applications, providing digital platform consulting and strategy,...